STUNS - The Foundation for Collaboration between the Universities in Uppsala, Business and Society
Treatment of Parkinson´s disease by recreating the endogenous L-Dopa/Dopamine production in midbrain
Our technology is based on the discovery and development of a method for harvesting, purification and culturing of non-manipulated, patient-own (autologous) cells that naturally produce high amounts of dopamine precursor. We believe that these cells will be viable after grafting to the brain and that a relatively simple stereotactic surgical procedure might present a highly potent method for inhibiting or curing Parkinson´s disease (PD). In the anticipated project we will ascertain safety, production and release of L-Dopa/Dopamine in vivo in an Parkinsonian model.